ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,930.85
      1.09%
      US Tech 100
      20,836.00
      1.31%
      Dow Jones
      42,840.26
      1.18%
      Brent Oil
      72.72
      0.00%
      Bitcoin
      96,479.93
      -0.75%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. LENSAR Inc (LNSR) Quote

      LENSAR Inc

      LENSAR Inc (LNSR)

      NASDAQ
      7.70
      0.20
      (2.67%)
      Closed December 22 4:00PM
      Delayed by 15 minutes
      7.685
      -0.015
      (-0.19%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      7.70
      Bid
      7.05
      Ask
      9.50
      Volume
      42,579
      7.35 Day's Range 7.88
      2.45 52 Week Range 8.17
      Market Cap
      89.434M
      Previous Close
      7.50
      Open
      7.46
      Last Trade
      1549
      @
      7.7
      (priorref)
      Last Trade Time
      Financial Volume
      $ 324,820
      VWAP
      7.6286
      Average Volume (3m)
      40,175
      Shares Outstanding
      11,614,807
      Dividend Yield
      -
      PE Ratio
      -6.20
      Earnings Per Share (EPS)
      -1.24
      Revenue
      42.16M
      Net Profit
      -14.38M

      About LENSAR Inc

      LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual out... LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit. Show more

      Sector
      Surgical,med Instr,apparatus
      Industry
      Surgical,med Instr,apparatus
      Website
      www.lensar.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      LENSAR Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker LNSR. The last closing price for LENSAR was $7.50. Over the last year, LENSAR shares have traded in a share price range of $ 2.45 to $ 8.17.

      LENSAR currently has 11,614,807 shares outstanding. The market capitalization of LENSAR is $87.11 million. LENSAR has a price to earnings ratio (PE ratio) of -6.20.

      Ask ADVFN Intelligence (AI)

      LNSR Latest News

      More News

      LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      ORLANDO, Fla., Dec. 09, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors...

      December 09 2024
      GlobeNewswire Inc.

      LENSAR to Participate in the BTIG 4th Annual Ophthalmology Day

      ORLANDO, Fla., Nov. 26, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced robotic laser solutions for the...

      November 26 2024
      GlobeNewswire Inc.

      Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

      November 14 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      November 07 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 07 2024
      Edgar (US Regulatory)

      LENSAR Reports Third Quarter 2024 Results and Provides Business Update

               24 ALLY Robotic Laser Cataract Systems™ placed in 3Q 2024 including 11 sales in EU and Southeast Asia; Robust backlog with 24 systems pending installation as of September 30, 2024 38...

      November 07 2024
      GlobeNewswire Inc.

      LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      ORLANDO, Fla., Nov. 01, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors...

      November 01 2024
      GlobeNewswire Inc.

      LENSAR to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024

      ORLANDO, Fla., Oct. 31, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced robotic laser solutions for the...

      October 31 2024
      GlobeNewswire Inc.

      One Millionth Procedure Completed Using LENSAR’s Cataract Laser Systems

      ORLANDO, Fla., Oct. 08, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the...

      October 08 2024
      GlobeNewswire Inc.

      LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      ORLANDO, Fla., Oct. 01, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors...

      October 01 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.08-1.028277634967.787.987.13418827.5440433CS
      40.253.355704697997.458.037422207.56175465CS
      123.2974.60317460324.418.174.2401756.62110191CS
      263.3175.39863325744.398.173.5316155.76169158CS
      525.09195.0191570882.618.172.45341144.76262627CS
      1561.6928.11980033286.018.81.8233504.38468721CS
      2604.54143.6708860763.1612.711.8287496.09427538CS

      LNSR - Frequently Asked Questions (FAQ)

      What is the current LENSAR share price?
      The current share price of LENSAR is $ 7.70
      How many LENSAR shares are in issue?
      LENSAR has 11,614,807 shares in issue
      What is the market cap of LENSAR?
      The market capitalisation of LENSAR is USD 87.11M
      What is the 1 year trading range for LENSAR share price?
      LENSAR has traded in the range of $ 2.45 to $ 8.17 during the past year
      What is the PE ratio of LENSAR?
      The price to earnings ratio of LENSAR is -6.2
      What is the cash to sales ratio of LENSAR?
      The cash to sales ratio of LENSAR is 2.12
      What is the reporting currency for LENSAR?
      LENSAR reports financial results in USD
      What is the latest annual turnover for LENSAR?
      The latest annual turnover of LENSAR is USD 42.16M
      What is the latest annual profit for LENSAR?
      The latest annual profit of LENSAR is USD -14.38M
      What is the registered address of LENSAR?
      The registered address for LENSAR is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
      What is the LENSAR website address?
      The website address for LENSAR is www.lensar.com
      Which industry sector does LENSAR operate in?
      LENSAR operates in the SURGICAL,MED INSTR,APPARATUS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      MYSZMy Size Inc
      $ 4.2001
      (211.12%)
      		121.03M
      NVNINVNI Group Ltd
      $ 8.26
      (209.36%)
      		78.06M
      TPICTPI Composites Inc
      $ 2.45
      (100.82%)
      		34M
      ICGIntchains Group Ltd
      $ 8.77
      (88.60%)
      		527.94k
      HSDTHelius Medical Technologies Inc
      $ 0.884851
      (84.34%)
      		121.95M
      CYNCYNGN Inc
      $ 0.4603
      (-71.41%)
      		27.91M
      MTEMMolecular Templates Inc
      $ 0.1502
      (-57.09%)
      		8.75M
      PRFXPainReform Ltd
      $ 5.15
      (-53.85%)
      		2.94M
      GALTGalectin Therapeutics Inc
      $ 1.03
      (-48.50%)
      		9.27M
      BCABBioAtla Inc
      $ 0.6923
      (-41.82%)
      		6.25M
      EDBLEdible Garden AG Inc
      $ 0.24
      (65.06%)
      		354.33M
      NVDANVIDIA Corporation
      $ 134.70
      (3.08%)
      		310.19M
      APTOAptose Biosciences Inc
      $ 0.28
      (64.51%)
      		306.25M
      TNXPTonix Pharmaceuticals Holding Corporation
      $ 0.606999
      (6.49%)
      		293.22M
      PLTRPalantir Technologies Inc
      $ 80.55
      (8.54%)
      		281.23M

      LNSR Discussion

      View Posts
      Monksdream Monksdream 1 month ago
      LNSR, new 52 week high
      👍️0
      Monksdream Monksdream 6 months ago
      LNSR under $5

      👍️ 1
      PonkenPlonken PonkenPlonken 8 months ago
      Company is very silent. maybe merger coming with Sight. Could complement well and help negotiating with BP
      👍️0
      crj0540 crj0540 4 years ago
      I really really like this one!
      👍️0
      Inspector121 Inspector121 4 years ago
      Where do you see this going near term?
      👍️0
      cantgetmyname cantgetmyname 4 years ago
      LNSR, Great start out of the gate.
      👍️0

      Your Recent History

      NASDAQ
      LNSR
      LENSAR
      NASDAQ
      BCAB
      BioAtla
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads